300 related articles for article (PubMed ID: 346288)
1. Individual differences in the disposition of drugs metabolised in the body.
Alvan G
Clin Pharmacokinet; 1978; 3(2):155-75. PubMed ID: 346288
[No Abstract] [Full Text] [Related]
2. Interindividual differences in drug oxidation: clinical importance.
Sjöqvist F; von Bahr C
Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420
[No Abstract] [Full Text] [Related]
3. Genetic factors in hepatic drug oxidation.
Kalow W; Inaba T
Prog Liver Dis; 1976; 5():246-58. PubMed ID: 775542
[No Abstract] [Full Text] [Related]
4. Editorial: Drug metabolism in disease.
Lancet; 1974 Apr; 1(7861):790-1. PubMed ID: 4132718
[No Abstract] [Full Text] [Related]
5. Drug disposition in children with protein energy malnutrition.
Mehta S
J Pediatr Gastroenterol Nutr; 1983; 2(3):407-17. PubMed ID: 6413666
[No Abstract] [Full Text] [Related]
6. [Inter-individual differences in pharmacokinetics in humans: clinical importance].
Sjöqvist F
Minerva Med; 1973 Mar; 64(17):866-79. PubMed ID: 4703858
[No Abstract] [Full Text] [Related]
7. Pharmacogenetics.
Du BN
Med Clin North Am; 1969 Jul; 53(4):839-55. PubMed ID: 4892640
[No Abstract] [Full Text] [Related]
8. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
Shrewsbury RP
Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of drug metabolism by hydroxylated metabolites: cross-inhibition and specificity.
Soda DM; Levy G
J Pharm Sci; 1975 Dec; 64(12):1928-31. PubMed ID: 1206483
[TBL] [Abstract][Full Text] [Related]
10. Interindividual differences in pharmacokinetics in man: clinical importance.
Sjöqvist F
Panminerva Med; 1973 Apr; 15(4):99-112. PubMed ID: 4808047
[No Abstract] [Full Text] [Related]
11. The Upjohn Award Lecture 1981/La Conférence Upjohn 1981. The metabolism of xenobiotics in different populations.
Kalow W
Can J Physiol Pharmacol; 1982 Jan; 60(1):1-12. PubMed ID: 7039786
[No Abstract] [Full Text] [Related]
12. Drug-induced liver injury.
van Berge Henegouwen GP; Vogten AJ
Neth J Med; 1980; 23(1):23-32. PubMed ID: 6988728
[No Abstract] [Full Text] [Related]
13. Interindividual differences in rates of drug oxidation in man.
Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
[No Abstract] [Full Text] [Related]
14. The importance of stable isotope labelled drugs in clinical pharmacology: with illustrations from studies on the disposition of propranolol and nortriptyline in man.
Gaffney TE; Knapp D; Walle T; Privitera P; Saelens D
South Med J; 1974 Aug; 67(8):990-1002. PubMed ID: 4854875
[No Abstract] [Full Text] [Related]
15. Impairment of drug metabolism in man by allopurinol and nortriptyline.
Vesell ES; Passananti GT; Greene FE
N Engl J Med; 1970 Dec; 283(27):1484-8. PubMed ID: 4098480
[No Abstract] [Full Text] [Related]
16. The hydroxylation of drugs- a pharmacogenetic problem?
Evans DA
Proc R Soc Med; 1970 Feb; 63(2):178. PubMed ID: 4191705
[No Abstract] [Full Text] [Related]
17. A new polymorphism of hepatic drug oxidation in man: family studies on rates of formation of antipyrine metabolites.
Vessell ES; Penno MB
Biochem Soc Trans; 1984 Feb; 12(1):74-8. PubMed ID: 6705993
[No Abstract] [Full Text] [Related]
18. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
Krakovskiĭ ME; Ashirmetov AKh
Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
[TBL] [Abstract][Full Text] [Related]
19. Drug metabolism in liver disease.
Prescott LF; Forrest JA; Adjepon-Yamoah KK; Finlayson ND
J Clin Pathol Suppl (R Coll Pathol); 1975; 9():62-5. PubMed ID: 783214
[No Abstract] [Full Text] [Related]
20. Route of administration and drug disposition.
Gibaldi M; Perrier D
Drug Metab Rev; 1974; 3(2):185-99. PubMed ID: 4607867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
